Literature DB >> 26644282

Evaluation of Antifungal Efficacy of 0.1% and 0.25% Riboflavin with UVA: A Comparative In Vitro Study.

Kamil Bilgihan1, Ayse Kalkanci2, Huseyin Baran Ozdemir1, Reyhan Yazar2, Funda Karakurt2, Erdem Yuksel1, Feza Otag3, Nilgun Karabicak4, Sevtap Arikan-Akdagli5.   

Abstract

PURPOSE: Antifungal efficacy of photochemical cross-linking (PACK-CXL) with 0.1% and 0.25% riboflavin was evaluated with a comparative in vitro study.
METHODS: Candida albicans and Aspergillus fumigatus ATCC reference strains, Candida parapsilosis, Aspergillus fumigatus, Fusarium solani, Scedosporium apiospermum, and Alternaria alternata strains isolated from keratitis cases were chosen as targeted microorganisms. Unique "black plate method" was developed in polystyrene microplates. Riboflavin suspensions in 0.1% and 0.25% were separately added into inoculated wells. Non-inoculated wells were filled by black colored dye in order to protect treated wells from reflection of UV treatment. After ultraviolet A (UVA) treatment, each well was evaluated by microbiological culture in order to count viable fungal colonies. Fungal killing rate was calculated by comparing fungal counts (CFU/mL) before and after UVA application of riboflavin-added wells.
RESULTS: Four different fungal inoculum concentrations of targeted microorganisms, including 104, 103, 102, and 101 CFU/mL, were assayed. PACK-CXL with 0.25% riboflavin was found to be highly effective on fungal cells even in 104 CFU/mL of concentration.
CONCLUSIONS: PACK-CXL appears as a promising treatment option for difficult-to-treat cases of fungal keratitis and 0.25% riboflavin concentration increases fungicidal effect of the procedure dramatically.

Entities:  

Keywords:  0.1% and 0.25% riboflavin; antifungal efficacy; black plate method; photochemical cross-linking (PACK-CXL)

Mesh:

Substances:

Year:  2015        PMID: 26644282     DOI: 10.3109/02713683.2015.1088956

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  7 in total

Review 1.  Review of clinical and basic approaches of fungal keratitis.

Authors:  Jie Wu; Wen-Song Zhang; Jing Zhao; Hong-Yan Zhou
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

2.  Comparison of modified corneal cross-linking with intrastromal voriconazole for the treatment of fungal corneal ulcer.

Authors:  Yingxin Chen; Xingya Miao; Minghong Gao; Lixin Song
Journal:  Exp Ther Med       Date:  2021-05-21       Impact factor: 2.447

3.  Antimicrobial efficacy of corneal cross-linking in vitro and in vivo for Fusarium solani: a potential new treatment for fungal keratitis.

Authors:  Ziqian Zhu; Hongmin Zhang; Juan Yue; Susu Liu; Zhijie Li; Liya Wang
Journal:  BMC Ophthalmol       Date:  2018-03-02       Impact factor: 2.209

Review 4.  The promise of endogenous and exogenous riboflavin in anti-infection.

Authors:  Junwen Lei; Caiyan Xin; Wei Xiao; Wenbi Chen; Zhangyong Song
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

5.  Comparison of Accelerated and Standard Corneal Collagen Cross-Linking Treatments in Experimental Fungal Keratitis for Aspergillus fumigatus.

Authors:  Anji Wei; Zhennan Zhao; Xiangmei Kong; Tingting Shao
Journal:  J Ophthalmol       Date:  2022-07-20       Impact factor: 1.974

6.  Comparison of Corneal Collagen Cross-Linking and Voriconazole Treatments in Experimental Fungal Keratitis for Aspergillus fumigatus.

Authors:  Zhennan Zhao; Xueli Chen; Yi Shao; Tingting Shao
Journal:  Front Med (Lausanne)       Date:  2022-06-28

7.  Commentary: PACK-CXL in fungal keratitis.

Authors:  Rashmi Deshmukh
Journal:  Indian J Ophthalmol       Date:  2019-10       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.